Eli Lilly, AtaiBeckley'i satın alıp Nasdaq'tan çıkışını başlattı
Investing.com TR
Summary · in our words
Eli Lilly, klinik aşamadaki biyofarmasötik şirketi AtaiBeckley'i satın aldı. İşlem sonrasında AtaiBeckley'in Nasdaq'tan çıkış süreci başlatıldı. Bu anlaşma, Eli Lilly'nin klinik aşamadaki bir şirket aracılığıyla biyofarmasötik sektöründe genişlemesini temsil ediyor.
Not investment advice.
The headline and data come from Investing.com TR. The summary and analysis are Mergen's own; the full article text is not republished here.
Related news
IPO & M&A
Nvidia in talks to invest $10B in Anthropic ahead of potential $2T IPO
13 hours ago · CointelegraphDetails →
IPO & M&AAnthropic pursues up to $10 billion investment from Nvidia ahead of IPO targeting up to $100 billion valuation
14 hours ago · ParaticDetails →
IPO & M&AKKR completes 2.1 billion dollar credit facility for Integer acquisition
1 day ago · Investing.com TRDetails →
IPO & M&ABetterLife Pharma files prospectus for $100 million initial public offering
1 day ago · Investing.com TRDetails →
IPO & M&AApollo Global Management in talks to acquire Johnson & Johnson's orthopedics unit for $20 billion
1 day ago · Investing.com TRDetails →
IPO & M&AEli Lilly acquires AtaiBeckley and initiates Nasdaq delisting
2 days ago · Investing.com TRDetails →